244 related articles for article (PubMed ID: 32957957)
1. Identification of lipid biomarker from serum in patients with chronic obstructive pulmonary disease.
Liu D; Meister M; Zhang S; Vong CI; Wang S; Fang R; Li L; Wang PG; Massion P; Ji X
Respir Res; 2020 Sep; 21(1):242. PubMed ID: 32957957
[TBL] [Abstract][Full Text] [Related]
2. Plasma Metabolomics and Lipidomics Reveal Perturbed Metabolites in Different Disease Stages of Chronic Obstructive Pulmonary Disease.
Zhou J; Li Q; Liu C; Pang R; Yin Y
Int J Chron Obstruct Pulmon Dis; 2020; 15():553-565. PubMed ID: 32210549
[TBL] [Abstract][Full Text] [Related]
3. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
[TBL] [Abstract][Full Text] [Related]
4. Study of the metabolomic relationship between lung cancer and chronic obstructive pulmonary disease based on direct infusion mass spectrometry.
Callejón-Leblic B; Pereira-Vega A; Vázquez-Gandullo E; Sánchez-Ramos JL; Gómez-Ariza JL; García-Barrera T
Biochimie; 2019 Feb; 157():111-122. PubMed ID: 30439409
[TBL] [Abstract][Full Text] [Related]
5. High-coverage lipidomics analysis reveals biomarkers for diagnosis of acute exacerbation of chronic obstructive pulmonary disease.
Liu X; Zhang H; Si Y; Du Y; Wu J; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jun; 1201-1202():123278. PubMed ID: 35561641
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia.
Arshad H; Alfonso JCL; Franke R; Michaelis K; Araujo L; Habib A; Zboromyrska Y; Lücke E; Strungaru E; Akmatov MK; Hatzikirou H; Meyer-Hermann M; Petersmann A; Nauck M; Brönstrup M; Bilitewski U; Abel L; Sievers J; Vila J; Illig T; Schreiber J; Pessler F
J Transl Med; 2019 Nov; 17(1):365. PubMed ID: 31711507
[TBL] [Abstract][Full Text] [Related]
7. Expression and Clinical Significance of Serum Dipeptidyl Peptidase IV Chronic Obstructive Pulmonary Disease.
Chang XY; Yang Y; Jia XQ; Wang Y; Peng LN; Ai XH; Jiang CY; Guo JH; Wu TT
Am J Med Sci; 2016 Mar; 351(3):244-52. PubMed ID: 26992252
[TBL] [Abstract][Full Text] [Related]
8. Metabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary disease.
Deja S; Porebska I; Kowal A; Zabek A; Barg W; Pawelczyk K; Stanimirova I; Daszykowski M; Korzeniewska A; Jankowska R; Mlynarz P
J Pharm Biomed Anal; 2014 Nov; 100():369-380. PubMed ID: 25213261
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Han YS; Chen JX; Li ZB; Chen J; Yi WJ; Huang H; Wei LL; Jiang TT; Li JC
Exp Biol Med (Maywood); 2021 Feb; 246(4):387-399. PubMed ID: 33175608
[TBL] [Abstract][Full Text] [Related]
10. Differentiation in TCM patterns of chronic obstructive pulmonary disease by comprehensive metabolomic and lipidomic characterization.
Li J; Liu X; Shi Y; Xie Y; Yang J; Du Y; Zhang A; Wu J
Front Immunol; 2023; 14():1208480. PubMed ID: 37492573
[TBL] [Abstract][Full Text] [Related]
11. Eicosanoids metabolized through LOX distinguish asthma-COPD overlap from COPD by metabolomics study.
Cai C; Bian X; Xue M; Liu X; Hu H; Wang J; Zheng SG; Sun B; Wu JL
Int J Chron Obstruct Pulmon Dis; 2019; 14():1769-1778. PubMed ID: 31496676
[TBL] [Abstract][Full Text] [Related]
12. Identification of thyroxine-binding globulin as a candidate plasma marker of chronic obstructive pulmonary disease.
Diao W; Shen N; Du Y; Sun X; Liu B; Xu M; He B
Int J Chron Obstruct Pulmon Dis; 2017; 12():1549-1564. PubMed ID: 28579773
[TBL] [Abstract][Full Text] [Related]
13. Lipid profile and atherogenic indices in patients with stable chronic obstructive pulmonary disease.
Markelić I; Hlapčić I; Rogić D; Rako I; Samaržija M; Popović-Grle S; Rumora L; Vukić Dugac A
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):153-161. PubMed ID: 32981798
[TBL] [Abstract][Full Text] [Related]
14. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
15. Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease.
Wang XR; Li YP; Gao S; Xia W; Gao K; Kong QH; Qi H; Wu L; Zhang J; Qu JM; Bai CX
Int J Chron Obstruct Pulmon Dis; 2014; 9():543-9. PubMed ID: 24920892
[TBL] [Abstract][Full Text] [Related]
16. Reduced Serum Concentration of CC16 Is Associated with Severity of Chronic Obstructive Pulmonary Disease and Contributes to the Diagnosis and Assessment of the Disease.
Rong B; Fu T; Gao W; Li M; Rong C; Liu W; Liu H
Int J Chron Obstruct Pulmon Dis; 2020; 15():461-470. PubMed ID: 32184583
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of undiagnosed chronic obstructive pulmonary disease in a primary care population with respiratory tract infections - a case finding study.
Sandelowsky H; Ställberg B; Nager A; Hasselström J
BMC Fam Pract; 2011 Nov; 12():122. PubMed ID: 22047519
[TBL] [Abstract][Full Text] [Related]
18. Validation of Breast Cancer Margins by Tissue Spray Mass Spectrometry.
Chagovets VV; Starodubtseva NL; Tokareva AO; Frankevich VE; Rodionov VV; Kometova VV; Chingin K; Kukaev EN; Chen H; Sukhikh GT
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604966
[TBL] [Abstract][Full Text] [Related]
19. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
